UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000019387
Receipt number R000022422
Scientific Title Pharmacokinetics of active ingredients by the intake of the functional food in healthy subjects
Date of disclosure of the study information 2016/10/27
Last modified on 2016/02/03 17:02:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Pharmacokinetics of active ingredients by the intake of the functional food in healthy subjects

Acronym

Pharmacokinetics of active ingredients by the intake of the functional food

Scientific Title

Pharmacokinetics of active ingredients by the intake of the functional food in healthy subjects

Scientific Title:Acronym

Pharmacokinetics of active ingredients by the intake of the functional food

Region

Japan


Condition

Condition

healthy adult subjects

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study to evaluate the pharmacokinetics of active ingredients by the intake of the functional food in healthy subjects

Basic objectives2

Bio-availability

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Cmax, Tmax

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Single ingestion of the functional food

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

50 years-old >

Gender

Male

Key inclusion criteria

Healthy adult males from 20 to 50 years of age

Key exclusion criteria

(1) Those who are gastrointestinal diseases and history (except the appendicitis)
(2) Those who are judged as inappropriate for the study based on the results of clinical examination and cardiopulmonary function by the investigator
(3) Those who have diseases such as diabetes, a liver disease, kidney disease, gastrointestinal disease, serious heart disease, skin disease, and diseases affecting the secretion of sex disease in the past or present, or have history
(4) Those who take the prescription drug (including external medicine)
(5) Those who might be liable to allergy related to the study (ex. food allergy)
(6) Those who participates in other clinical study at the start of the study or are planned to participate in other clinical study during the study
(7) Those who exceed donation criteria of the Japanese Red Cross within one year from the date of informed consent for the study
(8) Those who are judged as unsuitable for the study based on the results of body measurements, physical and clinical examination on preliminary examination
(9) Those who are judged as unsuitable for the study based on the results of lifestyle questionnaire
(10) Those who has been determined to be inappropriate of the study by the investigator

Target sample size

6


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kyoko Taguchi

Organization

Medical Corporation Ikuseikai, Yamaguchi hospital

Division name

Internal medicine

Zip code


Address

1-19-17 Nishisugamo, Toshima-ku, Tokyo

TEL

03-6663-8890

Email

info@synaps.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shingo Yamamichi

Organization

TTC Co., Ltd

Division name

Clinical Research Planning Department

Zip code


Address

1-20-2 Ebisunishi, shibuya-ku, Tokyo

TEL

03-5459-5329

Homepage URL


Email

s.yamamichi@ttc-tokyo.co.jp


Sponsor or person

Institute

TTC Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

non-disclosure

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 10 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 10 Month 16 Day

Date of IRB


Anticipated trial start date

2015 Year 10 Month 19 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 10 Month 16 Day

Last modified on

2016 Year 02 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022422


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name